February 10 2021 - Sanofi/Regeneron's Libtayo wins FDA approval for common skin cancer

February 10 2021 - Sanofi/Regeneron's Libtayo wins FDA approval for common skin cancer

Sanofi/Regeneron's Libtayo wins FDA approval for common skin cancer
Gilead's $5B Galapagos black hole widens as phase 3 asset is tossed
Eli Lilly scores EUA for COVID-19 antibody cocktail
As COVID-19 cases drop in the US, it could be the calm before a variant-driven storm
*please scroll down for all the latest news*

Stay updated with the latest pharma-related coronavirus news on our new page

Today's most popular searches: